Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award No cap on assistance (unless otherwise specified) · Income Income-based eligibility; threshold not published · Copayments, coinsurance, deductibles, health insurance premiums, incidental medical expenses
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
C82.0 C82.00 C82.01 C82.02 C82.03 C82.04 C82.05 C82.06 C82.07 C82.08 C82.09 C82.1 C82.10 C82.9 C82.90 C83.0 C83.3 C83.30 C83.31 C83.32 C83.33 C83.34 C83.35 C83.36 C83.37 C83.38 C83.39 C83.5 C83.8 C83.9 C83.90 C85.1 C85.9 C85.90 C91.1 C91.10 C91.11 L10.0 M05.79 M06.9 M31.30 M31.31 M31.7 M32.14Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Also matches J-codes not yet in our drug library: J9075 J9268 J9311 J9349 Q5123
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 833-844-5182, and check the alternatives below.
Manufacturer copay programs may also apply — see the drug pages: Bendeka, Columvi, Gazyva, Polivy.
Status shown as of each fund's last verification.
As of June 18, 2026, the The Assistance Fund B-Cell Lymphoma fund is operating a WAITLIST. Call the foundation to confirm current intake. Verify at time of service: 833-844-5182.
No cap on assistance (unless otherwise specified). Copayments, coinsurance, deductibles, health insurance premiums, incidental medical expenses
Household income must be Income-based eligibility; threshold not published. U.S. resident.
Accepted: commercial, medicare, medicaid.